Bayesian Analysis with R for Drug Development
-10%
portes grátis
Bayesian Analysis with R for Drug Development
Concepts, Algorithms, and Case Studies
Yang, Harry; Novick, Steven
Taylor & Francis Ltd
07/2019
310
Dura
Inglês
9781138295872
15 a 20 dias
825
Descrição não disponível.
Background. Drug Research and Development. Basics of Bayesian analysis. Bayesian Estimation of Sample Size and Power. Pre-Clinical and Clinical Research. Pre-clinical efficacy study. Futility analysis. Phase 3 Clinical Trial. Chemistry, Manufacturing, and Control. Analytical method. Process Development. Bayesian Approach to Statistical Process Control.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Random Effect Logistic Model;Pre-Clinical Studies;MCMC Sampling;Pharmaceutical Development;Posterior Predictive Distribution;Clinical Trials;Multi-region Trials;Markov Chain Monte Carlo Simulation;Posterior Distribution;Chemistry, Manufacturing, and Control (CMC);Cumulative Distribution Function;Quality by Design;Posterior Predictive Probability;Stan Bayesian software platform;Ich Q8;R code;Consecutive Daily Samples;experimental drug;Non-conjugate Prior;Interim Analysis;FDA 2011a;Ich Q1E;Residual DNA;SUR Model;CRM;Emax Model;Tolerance Interval;Baseline Tumor Size;Dose Ranging Studies;Predictive Probability;Sample Size Calculations;REML Estimate;Zip Distribution;Control Charts
Background. Drug Research and Development. Basics of Bayesian analysis. Bayesian Estimation of Sample Size and Power. Pre-Clinical and Clinical Research. Pre-clinical efficacy study. Futility analysis. Phase 3 Clinical Trial. Chemistry, Manufacturing, and Control. Analytical method. Process Development. Bayesian Approach to Statistical Process Control.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Random Effect Logistic Model;Pre-Clinical Studies;MCMC Sampling;Pharmaceutical Development;Posterior Predictive Distribution;Clinical Trials;Multi-region Trials;Markov Chain Monte Carlo Simulation;Posterior Distribution;Chemistry, Manufacturing, and Control (CMC);Cumulative Distribution Function;Quality by Design;Posterior Predictive Probability;Stan Bayesian software platform;Ich Q8;R code;Consecutive Daily Samples;experimental drug;Non-conjugate Prior;Interim Analysis;FDA 2011a;Ich Q1E;Residual DNA;SUR Model;CRM;Emax Model;Tolerance Interval;Baseline Tumor Size;Dose Ranging Studies;Predictive Probability;Sample Size Calculations;REML Estimate;Zip Distribution;Control Charts
